Stéphane de Botton

24PUBLICATIONS
137CO-AUTHORS
Haematological tumoursMedical infection agents (incl. prions)Liquid biopsiesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Oct 27, 2026
Prognostic Impact of FLT3-ITD Allelic Ratio in AML Patients Treated With High-Dose Anthracycline and a FLT3 Inhibitor.

|May 21, 2026
Prognostic impact of FLT3-ITD microclones in young adults with acute myeloid leukemia treated with intensive chemotherapy.

|May 12, 2026
Comprehensive mutational profiling and clinical outcome of adult acute myeloid leukemia patients with NUP98 rearrangement.

|Sep 24, 2025
CAR T cell-mediated bone marrow inflammation causes hematotoxicity and favors clonal hematopoiesis.

Myriam Ben Khelil, Ahmadreza Arbab, Janesa Srikanthan

|Jul 24, 2025
Long-term results from the AGILE study of azacitidine plus ivosidenib vs placebo in newly diagnosed IDH1-mutated AML.

Pau Montesinos, Dylan M Marchione, Christian Recher

|May 07, 2025
Pivotal results of SELECT-MDS-1 phase 3 study of tamibarotene with azacitidine in newly diagnosed higher-risk MDS.

Amy E DeZern, Sylvain Thepot, Stephane de Botton

Pageof 4

Frequent Collaborators

8 joint publications

Christian Recher

7 joint publications

Nicolas Duployez

6 joint publications

Courtney D DiNardo

6 joint publications

Raphaël Itzykson